Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract.

Kriegel C, Attarwala H, Amiji M.

Adv Drug Deliv Rev. 2013 Jun 15;65(6):891-901. doi: 10.1016/j.addr.2012.11.003. Epub 2012 Dec 7. Review.

PMID:
23220324
2.

Development of novel biodegradable polymeric nanoparticles-in-microsphere formulation for local plasmid DNA delivery in the gastrointestinal tract.

Bhavsar MD, Amiji MM.

AAPS PharmSciTech. 2008;9(1):288-94. doi: 10.1208/s12249-007-9021-9. Epub 2008 Jan 18.

3.

Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery.

Xu J, Ganesh S, Amiji M.

Int J Pharm. 2012 May 1;427(1):21-34. doi: 10.1016/j.ijpharm.2011.05.036. Epub 2011 May 19. Review.

4.

Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease.

Kriegel C, Amiji M.

J Control Release. 2011 Feb 28;150(1):77-86. doi: 10.1016/j.jconrel.2010.10.002. Epub 2010 Oct 17.

5.

Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS).

Bhavsar MD, Amiji MM.

J Control Release. 2007 Jun 22;119(3):339-48. Epub 2007 Mar 15.

PMID:
17475358
6.

Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease.

Bhavsar MD, Amiji MM.

Gene Ther. 2008 Sep;15(17):1200-9. doi: 10.1038/gt.2008.67. Epub 2008 Apr 17.

PMID:
18418416
7.

Ternary polymeric nanoparticles for oral siRNA delivery.

Zhang J, He C, Tang C, Yin C.

Pharm Res. 2013 May;30(5):1228-39. doi: 10.1007/s11095-012-0961-8. Epub 2013 Jan 10.

PMID:
23307349
8.

Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.

Yun Y, Cho YW, Park K.

Adv Drug Deliv Rev. 2013 Jun 15;65(6):822-32. doi: 10.1016/j.addr.2012.10.007. Epub 2012 Nov 2. Review.

9.

Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules.

Chen MC, Mi FL, Liao ZX, Hsiao CW, Sonaje K, Chung MF, Hsu LW, Sung HW.

Adv Drug Deliv Rev. 2013 Jun 15;65(6):865-79. doi: 10.1016/j.addr.2012.10.010. Epub 2012 Nov 15. Review.

PMID:
23159541
10.

Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration.

de Wolf HK, Snel CJ, Verbaan FJ, Schiffelers RM, Hennink WE, Storm G.

Int J Pharm. 2007 Mar 1;331(2):167-75. Epub 2006 Oct 26.

PMID:
17134859
11.

Pharmaceutical nanotechnology for oral delivery of anticancer drugs.

Mei L, Zhang Z, Zhao L, Huang L, Yang XL, Tang J, Feng SS.

Adv Drug Deliv Rev. 2013 Jun 15;65(6):880-90. doi: 10.1016/j.addr.2012.11.005. Epub 2012 Dec 7. Review.

PMID:
23220325
12.

Oral delivery of proteins by biodegradable nanoparticles.

Bakhru SH, Furtado S, Morello AP, Mathiowitz E.

Adv Drug Deliv Rev. 2013 Jun 15;65(6):811-21. doi: 10.1016/j.addr.2013.04.006. Epub 2013 Apr 20. Review.

PMID:
23608641
13.

Research progress on siRNA delivery with nonviral carriers.

Gao Y, Liu XL, Li XR.

Int J Nanomedicine. 2011;6:1017-25. doi: 10.2147/IJN.S17040. Epub 2011 May 11. Review.

14.

Oral drug delivery systems using chemical conjugates or physical complexes.

Al-Hilal TA, Alam F, Byun Y.

Adv Drug Deliv Rev. 2013 Jun 15;65(6):845-64. doi: 10.1016/j.addr.2012.11.002. Epub 2012 Dec 7. Review.

PMID:
23220326
15.

Progress in nanoparticulate systems for peptide, proteins and nucleic acid drug delivery.

Slomkowski S, Gosecki M.

Curr Pharm Biotechnol. 2011 Nov;12(11):1823-39. Review.

PMID:
21902630
16.

Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.

Kuruba R, Wilson A, Gao X, Li S.

AAPS J. 2009 Mar;11(1):23-30. doi: 10.1208/s12248-008-9073-0. Epub 2009 Jan 9. Review.

17.

Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.

Li J, Wang Y, Zhu Y, Oupický D.

J Control Release. 2013 Dec 10;172(2):589-600. doi: 10.1016/j.jconrel.2013.04.010. Epub 2013 Apr 25. Review.

18.

N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver.

Wang HX, Xiong MH, Wang YC, Zhu J, Wang J.

J Control Release. 2013 Mar 10;166(2):106-14. doi: 10.1016/j.jconrel.2012.12.017. Epub 2012 Dec 20.

PMID:
23266452
19.

Self-assembled and nanostructured siRNA delivery systems.

Jeong JH, Park TG, Kim SH.

Pharm Res. 2011 Sep;28(9):2072-85. doi: 10.1007/s11095-011-0412-y. Epub 2011 Mar 18. Review.

PMID:
21424157
20.

Nanodelivery systems for nucleic acid therapeutics in drug resistant tumors.

Iyer AK, Duan Z, Amiji MM.

Mol Pharm. 2014 Aug 4;11(8):2511-26. doi: 10.1021/mp500024p. Epub 2014 Apr 1. Review.

PMID:
24661041
Items per page

Supplemental Content

Write to the Help Desk